NIH: National Institute on Aging Scholars Program: 

  • The NIA Butler-Williams Scholars Program (formerly the Summer Institute on Aging Research) is accepting applications for an intensive introduction to aging research. This program for investigators who are new to aging research is focused on the breadth of research supported by the National Institute on Aging, including basic biology, neuroscience, behavioral and social research, geriatrics and clinical gerontology. As an offering through the NIA Office of Special Populations, program content will include a focus on health disparities, research methodologies, and funding opportunities. The 2018 B-W Scholars Program will be held July 30-August 3, 2018 in Bethesda, Maryland. Support in most cases is available for travel and living expenses. LOI deadline: March 23, 2018:

National Institutes of Health: 

  • Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease: This FOA invites applications for basic research to better characterize the affective, cognitive, social, and motivational parameters of impaired and intact decision making in both normal aging and Alzheimer's disease (AD). Research is sought that will characterize the extent to which basic behavioral and neural processes involved in decision making are differentially impacted in normal aging and AD, investigate the influence of social factors on decision making, and investigate the decision-making factors that render older adults (with or without cognitive impairment) vulnerable to financial exploitation and other forms of mistreatment and abuse. The FOA also invites applications to apply basic research on the processes involved in decision making to the design of decision-supportive interventions for midlife and older adults with and without AD. Specific opportunities include the development of decision-supportive interventions to leverage cognitive, emotional and motivational strengths of these populations; tools to assess decisional capacity; strategies for simplifying choices and offering better defaults; and the promotion of timely adoption of optimal delegation practices (e.g., power of attorney, living wells, etc.). Deadlines: March 29, 2018; June 8, 2018; February 8, 2019; June 8, 2019; February 20, 2020; and June 8, 2020
  • Centers of Excellence for Translational Research (CETR): This FOA solicits applications from single institutions or consortia of institutions to participate in the Centers for Excellence in Translational Research (CETR) program. The purpose of this program is to support multidisciplinary translational research centers focused on generating, validating and advancing medical countermeasures to select NIAID Emerging Infectious Diseases/Pathogens. Budget: Up to $5M in direct costs for up to 5 years. LOI deadline: February 28, 2018. Full proposal deadline: March 30, 2018. 
  • Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional): This program seeks to broaden and strengthen translational research collaborations between basic and clinical researchers both within and outside NIH to accelerate and enhance translational science by promoting partnerships between NIH intramural and extramural investigators, and by providing support for extramural investigators to take advantage of the unique research opportunities available at the NIH Clinical Center by conducting research projects in collaboration with NIH intramural investigators. Deadline: April 11, 2018 by 5 p.m. (earliest submission date is March 11, 2018). 
  • Genomic Centers for Infectious Diseases: This initiative supports Genomic Centers for Infectious Diseases to promote broad use and expand the application of genomics technologies and computational analysis to understand infectious diseases, with an emphasis on pathogens, their interaction with the host and microbiome, and to aid in the development of novel genomics-based tools to diagnose, prevent and treat infectious diseases. The GCID will support innovative technology development in all aspects of genomics, including the use of synthetic and genome editing technologies as well as functional genomics to address basic, translational, and clinically relevant questions in host-pathogen interactions. The knowledge generated, including research data, analytical software tools, computational models, experimental protocols, and reagents, is expected to be widely disseminated to the scientific community through publicly accessible databases and reagent repositories. Budget: Up to $3.75 million in direct costs per year. LOI Deadline: May 22, 2018. Full application deadline: June 22, 2018. 
  • National Centers for Translational Research in Reproduction and Infertility (P50 Clinical Trial Optional): The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), through the Fertility and Infertility (FI) and the Gynecological, Health and Disease (GHD) Branches, provides funding for a limited number of research centers in the reproductive and gynecological sciences. For the purpose of this FOA, reproductive health includes both fertility/infertility and gynecological health. These centers provide an arena for multidisciplinary interactions among basic and clinical scientists interested in establishing high quality translational research programs in these scientific areas. The centers also serve as national resources for the training and career development of junior scientists electing to pursue biomedical research careers in reproductive health. Finally, center investigators develop and participate in community outreach and education efforts to increase awareness and convey the importance and implications of their research activities to the general public. Budget: Up to $1.2 million per year for up to five years. LOI deadline: May, 29 2018. Full application deadline: June 29 2018.

Center for Vision Research: 

  • Call for Applications: The Center for Vision Research, part of the Brown Institute for Brain Science, has funds to facilitate innovative vision research through pilot grants and temporary support of postdoctoral fellows. Funds are also available to bring speakers to campus and to host workshops. Applications for these funds will be reviewed on a rolling basis beginning in April 2018. 

Lifespan Center for Cancer Research Development (CCRD):

  • Pilot Grant Program: This program will provide support for promising junior faculty members undertaking cancer research. Up to three, two-year pilot projects at $50,000 direct costs per year are anticipated for funding. Investigators will have preferred access to the CCRD’s proteomics and molecular pathology core facilities. Deadline: April 2, 2018 by 5 p.m. 

Providence/Boston Center for AIDS Research (CFAR):

  • The CFAR Developmental Grant Program provides support for three types of AIDS biomedical and behavioral research projects (initial AIDS research projects, pilot projects testing new or innovative ideas, and collaborative projects).  Proposals addressing HIV & Substance Use or HIV & TB will be prioritized. Applications will be accepted from faculty members within the following institutions:  Lifespan affiliated hospitals, Brown University, Boston University and Boston Medical Center.  Application deadline: April 2, 2018 by 5 p.m. 
Get feedback on your proposal before you submit! CFAR is now offering “Think Tank Sessions” prior to the application due dates.  During these sessions, interested investigators will have the opportunity to present their ideas and get feedback from CFAR senior faculty as well as learn what services the CFAR Cores provide to assist in advancing your HIV research.   If you would like to participate in an upcoming session or would like more information, please go to the CFAR Website
  • Supplemental Program: CFAR invites applications from HIV investigators and established investigators in non-HIV fields who have never received an R01 for HIV/AIDS studies, but may have received other R (i.e., R21, R34) or K series awards, to apply for internal supplemental funds in three scientific areas of interest:
    • Basic Research on HIV infection and Persistence
    • The Evolving Opioid Epidemic and its HIV Consequences
    • Implementation of Evidence-Based HIV Interventions and Treatments for Health Disparity Populations
The awards are for one year with maximum funding per application of up to $50,000 Direct Costs, indirect costs not allowed.  If awarded, projects must be activated no later than June 22, 2018. Deadline: April 2, 2018 by 5 p.m.

American Federation for Aging Research:

  • The New Investigator Awards in Alzheimer's Disease: The program will fund applications in basic, translational and clinical research related to Alzheimer’s disease and healthy brain aging. It is anticipated that up to 3 grants of $50,000 each will be awarded in 2018, with the stipulation that 1:1 matching funds are contributed by the applicant’s institution, bringing the total award amount to $100,000. Applicants may propose to use the award over the course of one or two years as justified by the proposed research. LOI deadline: April 13, 2018 at 5 p.m. EST. Funding will begin October 1, 2018.

EMD Serono: 

  • Displaying Futures Award: Calling scientists and aspiring entrepreneurs! With the Displaying Futures Award, we expand boundaries in the Performance Materials field and fosters entrepreneurial spirit. Submit your innovation for the Displaying Futures Award from February 5 to April 15, 2018. This year’s award focuses on smart medical devices, specifically in the areas of wearables, electronic implants and beyond. Learn more.

Brown Institute for Brain Science: 

  • Innovation Awards: The purpose of these awards is to help brain scientists launch new, innovative research projects with great potential that are too risky and early stage for NIH or other external funding sources. BIBS will make significant investments of up to $100K for one year, renewable for a second year on a competitive basis. Deadline: June 15, 2018. 

Department of Health and Human Services: 

  • T1 Translational Research: Novel Interventions for Prevention and Treatment of Age-related Conditions (R21 Clinical Trial Optional): This FOA encourages exploratory/developmental research projects to accelerate the pace of development of novel therapeutics involving biologics, pharmacological and non-pharmacological approaches for preventing and treating key health issues affecting the elderly. For the purposes of this FOA, T1 translational research on aging is defined as the application of basic and clinical biomedical findings towards the development of new strategies for prevention and treatment of age-related pathologies. Budget: The combined budget for direct costs for the two-year project period may not exceed $275,000.  No more than $200,000 in direct costs may be requested in any single year. Deadline: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Earliest submission date is January 17, 2018.
  • Maximizing Investigators' Research Award for Early Stage Investigators (R35): The grant will provide support for the program of research in an early stage investigator's laboratory that falls within the mission of NIGMS. For the purpose of this FOA, a program of research is the collection of projects in the investigator's lab that are relevant to the mission of NIGMS. Budget: Applications may request up to $250,000 in direct costs per year for a maximum project period of five years. Applications due October 3, 2018; and October 3, 2019 by 5 p.m. local time of applicant organization. 

National Institute of Allergy and Infectious Diseases (NIAID): 

  • Physician-Scientist Pathway to Independence Award (K99/R00): This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIAID research support during this transition to help awardees launch competitive, independent research careers in biomedical fields and thereby help to address the national physician-scientist workforce shortage. Deadlines: NIH’s Standard Due Dates and Standard AIDS Dates apply.

Diabetes Research & Wellness Foundation: 

  • Research applications related to finding the cause, prevention, treatment, and cure of diabetes and its complications. Applications accepted year-round. 

US Army Medical and Materiel Command’s (USAMRMC):

  • FY18-FY22 BAA for Extramural Medical Research: To study a variety of science & medical topics that provide solutions to medical problems of importance to the American Service member at home and abroad, as well as to the general public at large. Award Amount: not specified; award Duration: 2-5 years. LOIs Due: required, but no deadline; full proposals duerolling through September 30, 2022. 

Online Partnership to Accelerate Research: 

  • Leidos Health has partnered with NIH to accelerate the biomedical research and development enterprise by matching high-scoring (e.g., those within the 30th percentile), unfunded NIH applications with private biomedical foundations and/or industries seeking to fund promising research via OnPAR. Learn more.

National Institutes of Health & Department of Health and Human Services:

University of Vermont I-Trep Program: